{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T21:58:30Z","timestamp":1712267910835},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T00:00:00Z","timestamp":1519689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00105-018-4135-4","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T11:08:11Z","timestamp":1519729691000},"page":"210-216","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Externe Therapie des atopischen Ekzems"],"prefix":"10.1007","volume":"69","author":[{"given":"M.","family":"Knop","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"G\u00fcrtler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heratizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Aszodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Werfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Wollenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,27]]},"reference":[{"key":"4135_CR1","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/sj.jid.5700622","volume":"127","author":"FM Arellano","year":"2007","unstructured":"Arellano FM, Wentworth CE, Arana A et\u00a0al (2007) Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J\u00a0Invest Dermatol 127:808\u2013816","journal-title":"J Invest Dermatol"},{"key":"4135_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/CCID.S113180","volume":"9","author":"MF Aries","year":"2016","unstructured":"Aries MF, Hernandez-Pigeon H, Vaissiere C et al (2016) Anti-inflammatory and immunomodulatory effects of Aquaphilus dolomiae extract on in vitro models. Clin Cosmet Investig Dermatol 9:421\u2013434","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"4135_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaip.2012.09.002","volume":"1","author":"PD Arkwright","year":"2013","unstructured":"Arkwright PD, Motala C, Subramanian H et al (2013) Management of difficult-to-treat atopic dermatitis. J\u00a0Allergy Clin Immunol Pract 1:142\u2013151","journal-title":"J Allergy Clin Immunol Pract"},{"key":"4135_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/all.12857","volume":"71","author":"T Bieber","year":"2016","unstructured":"Bieber T, Akdis C, Lauener R et\u00a0al (2016) Global allergy forum and 3rd Davos declaration 2015: atopic dermatitis\/eczema: challenges and opportunities toward precision medicine. Allergy 71:588\u2013592","journal-title":"Allergy"},{"key":"4135_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/bjd.14871","volume":"175","author":"R Bissonnette","year":"2016","unstructured":"Bissonnette R, Papp KA, Poulin Y et\u00a0al (2016) Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol 175:902\u2013911","journal-title":"Br J Dermatol"},{"key":"4135_CR6","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1468-3083.2009.03140.x","volume":"23","author":"U Blume-Peytavi","year":"2009","unstructured":"Blume-Peytavi U, Cork MJ, Faergemann J et al (2009) Bathing and cleansing in newborns from day 1 to first year of life: recommendations from a\u00a0European round table meeting. J\u00a0Eur Acad Dermatol Venereol 23:751\u2013759","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4135_CR7","first-page":"191","volume":"62","author":"M Bourrain","year":"2012","unstructured":"Bourrain M, Villette C, Nguyen T et\u00a0al (2012) Aquaphilus dolomiae gen. nov., . nov., isolated from a\u00a0deep aquifer. Vie Milieu 62:191\u2013195","journal-title":"Vie Milieu"},{"key":"4135_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1939-4551-6-6","volume":"6","author":"U Darsow","year":"2013","unstructured":"Darsow U, Wollenberg A, Simon D et\u00a0al (2013) Difficult to control atopic dermatitis. World Allergy Organ\u00a0J 6:6","journal-title":"World Allergy Organ J"},{"key":"4135_CR9","first-page":"834","volume":"96","author":"M Deleuran","year":"2016","unstructured":"Deleuran M, Vestergaard C, Volund A et\u00a0al (2016) Topical Calcineurin Inhibitors, Topical Glucocorticoids and Cancer in Children: A Nationwide Study. Acta Dermato-Venereologica 96:834\u2013835","journal-title":"Acta Dermato-Venereologica"},{"key":"4135_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000070935","volume":"207","author":"A Gauger","year":"2003","unstructured":"Gauger A, Mempel M, Schekatz A et al (2003) Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology 207:15\u201321","journal-title":"Dermatology"},{"key":"4135_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1468-3083.2006.01526.x","volume":"20","author":"A Gauger","year":"2006","unstructured":"Gauger A, Fischer S, Mempel M et al (2006) Efficacy and functionality of silver-coated textiles in patients with atopic eczema. J\u00a0Eur Acad Dermatol Venereol 20:534\u2013541","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"4135_CR12","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/bjd.12957","volume":"170","author":"C Gelmetti","year":"2014","unstructured":"Gelmetti C, Wollenberg A (2014) Atopic dermatitis \u2013 all you can do from the outside. Br J Dermatol 170(Suppl 1):19\u201324","journal-title":"Br J Dermatol"},{"key":"4135_CR13","first-page":"1394","volume":"14","author":"SLF Gold","year":"2015","unstructured":"Gold SLF, Spelman L, Spellman MC et al (2015) A phase 2, randomized, controlled, dose-ranging study evaluating crisaborole topical ointment, 0.5\u202f% and 2\u202f% in adolescents with mild to moderate atopic dermatitis. J\u00a0Drugs Dermatol 14:1394\u20131399","journal-title":"J Drugs Dermatol"},{"key":"4135_CR14","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1365-2133.2008.08836.x","volume":"159","author":"A Gueniche","year":"2008","unstructured":"Gueniche A, Knaudt B, Schuck E et al (2008) Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: a\u00a0prospective, randomized, double-blind, placebo-controlled clinical study. Br J Dermatol 159:1357\u20131363","journal-title":"Br J Dermatol"},{"key":"4135_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00105-014-3559-8","volume":"66","author":"A Heratizadeh","year":"2015","unstructured":"Heratizadeh A, Werfel T, Rosner LM (2015) Adaptive immune response and associated trigger factors in atopic dermatitis. Hautarzt 66:96\u2013102","journal-title":"Hautarzt"},{"key":"4135_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jaci.2017.01.029","volume":"140","author":"A Heratizadeh","year":"2017","unstructured":"Heratizadeh A, Werfel T, Wollenberg A et\u00a0al (2017) Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J\u00a0Allergy Clin Immunol 140:845\u2013853.e3","journal-title":"J Allergy Clin Immunol"},{"key":"4135_CR17","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaci.2014.07.060","volume":"134","author":"K Horimukai","year":"2014","unstructured":"Horimukai K, Morita K, Narita M et\u00a0al (2014) Application of moisturizer to neonates prevents development of atopic dermatitis. J\u00a0Allergy Clin Immunol 134:824\u2013830.e6","journal-title":"J Allergy Clin Immunol"},{"key":"4135_CR18","first-page":"30","volume":"38","author":"S Hradetzky","year":"2015","unstructured":"Hradetzky S, Heratizadeh A (2015) Malassezia sympodialis und atopische Dermatitis. Allergologie 38:30\u201337","journal-title":"Allergologie"},{"key":"4135_CR19","doi-asserted-by":"publisher","first-page":"e808","DOI":"10.1542\/peds.2008-2217","volume":"123","author":"JT Huang","year":"2009","unstructured":"Huang JT, Abrams M, Tlougan B et\u00a0al (2009) Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 123:e808\u2013e814","journal-title":"Pediatrics"},{"key":"4135_CR20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1101\/gr.131029.111","volume":"22","author":"HH Kong","year":"2012","unstructured":"Kong HH, Oh J, Deming C et\u00a0al (2012) Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22:850\u2013859","journal-title":"Genome Res"},{"key":"4135_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000100879","volume":"214","author":"DJ Margolis","year":"2007","unstructured":"Margolis DJ, Hoffstad O, Bilker W (2007) Lack of association between exposure to topical calcineurin inhibitors and skin cancer in adults. Dermatology 214:289\u2013295","journal-title":"Dermatology"},{"key":"4135_CR22","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1523-1747.ep12514346","volume":"67","author":"MC Mihm","year":"1976","unstructured":"Mihm MC, Soter NA, Dvorak HF et\u00a0al (1976) The structure of normal skin and the morphology of atopic eczema. J\u00a0Invest Dermatol 67:305\u2013312","journal-title":"J Invest Dermatol"},{"key":"4135_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4680","author":"T Nakatsuji","year":"2017","unstructured":"Nakatsuji T, Chen TH, Narala S et\u00a0al (2017) Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aah4680","journal-title":"Sci Transl Med"},{"issue":"4","key":"4135_CR24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/pde.12871","volume":"33","author":"I Neri","year":"2016","unstructured":"Neri I, Dondi A, Wollenberg A et\u00a0al (2016) Atypical forms of hand, foot, and mouth disease: a prospective study of 47 Italian children. Pediatr Dermatol 33(4):429. https:\/\/doi.org\/10.1111\/pde.12871","journal-title":"Pediatr Dermatol"},{"key":"4135_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.iac.2016.08.003","volume":"37","author":"NH Nicol","year":"2017","unstructured":"Nicol NH, Boguniewicz M (2017) Wet wrap therapy in moderate to severe atopic dermatitis. Immunol Allergy Clin North Am 37:123\u2013139","journal-title":"Immunol Allergy Clin North Am"},{"key":"4135_CR26","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1600-0625.2008.00734.x","volume":"17","author":"M Niebuhr","year":"2008","unstructured":"Niebuhr M, Mai U, Kapp A et\u00a0al (2008) Antibiotic treatment of cutaneous infections with Staphylococcus aureus in patients with atopic dermatitis: current antimicrobial resistances and susceptibilities. Exp Dermatol 17:953\u2013957","journal-title":"Exp Dermatol"},{"key":"4135_CR27","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","volume":"75","author":"AS Paller","year":"2016","unstructured":"Paller AS, Tom WL, Lebwohl MG et\u00a0al (2016) Efficacy and safety of crisaborole ointment, a\u00a0novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. J\u00a0Am Acad Dermatol 75:494\u2013503.e6","journal-title":"J Am Acad Dermatol"},{"key":"4135_CR28","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/ng.3424","volume":"47","author":"L Paternoster","year":"2015","unstructured":"Paternoster L, Standl M, Waage J et al (2015) Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat Genet 47:1449\u20131456","journal-title":"Nat Genet"},{"key":"4135_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jdermsci.2006.06.003","volume":"43","author":"E Proksch","year":"2006","unstructured":"Proksch E, Folster-Holst R, Jensen JM (2006) Skin barrier function, epidermal proliferation and differentiation in eczema. J\u00a0Dermatol Sci 43:159\u2013169","journal-title":"J Dermatol Sci"},{"key":"4135_CR30","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00105-006-1168-x","volume":"57","author":"HC Rerinck","year":"2006","unstructured":"Rerinck HC, Kamann S, Wollenberg A (2006) Eczema herpeticatum: Pathogenese und Therapie. Hautarzt 57:586\u2013591","journal-title":"Hautarzt"},{"issue":"8","key":"4135_CR31","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","volume":"26","author":"J Ring","year":"2012","unstructured":"Ring J, Alomar A, Bieber T et\u00a0al (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J\u00a0Eur Acad Dermatol Venereol 26(8):1045\u20131060. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04635.x","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"9","key":"4135_CR32","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1468-3083.2012.04636.x","volume":"26","author":"J Ring","year":"2012","unstructured":"Ring J, Alomar A, Bieber T et\u00a0al (2012) Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J\u00a0Eur Acad Dermatol Venereol 26(9):1176\u20131193. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04636.x","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"4135_CR33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","volume":"134","author":"EL Simpson","year":"2014","unstructured":"Simpson EL, Chalmers JR, Hanifin JM et\u00a0al (2014) Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J\u00a0Allergy Clin Immunol 134:818\u2013823","journal-title":"J Allergy Clin Immunol"},{"key":"4135_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jaad.2017.06.042","volume":"77","author":"EL Simpson","year":"2017","unstructured":"Simpson EL, Bruin-Weller M, Flohr C et al (2017) When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J\u00a0Am Acad Dermatol 77:623\u2013633","journal-title":"J Am Acad Dermatol"},{"key":"4135_CR35","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1136\/bmj.332.7547.933","volume":"332","author":"D Staab","year":"2006","unstructured":"Staab D, Diepgen TL, Fartasch M et\u00a0al (2006) Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 332:933\u2013938","journal-title":"BMJ"},{"key":"4135_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/pde.12024","volume":"30","author":"JF Stalder","year":"2013","unstructured":"Stalder JF, Bernier C, Ball A et\u00a0al (2013) Therapeutic patient education in atopic dermatitis: worldwide experiences. Pediatr Dermatol 30:329\u2013334","journal-title":"Pediatr Dermatol"},{"key":"4135_CR37","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/all.13189","volume":"72","author":"JF Stalder","year":"2017","unstructured":"Stalder JF, Aubert H, Anthoine E et\u00a0al (2017) Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score. Allergy 72:1713\u20131719","journal-title":"Allergy"},{"key":"4135_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jaci.2012.11.010","volume":"131","author":"M Suarez-Farinas","year":"2013","unstructured":"Suarez-Farinas M, Gittler JK, Shemer A et al (2013) Residual genomic signature of atopic dermatitis despite clinical resolution with narrow-band UVB. J\u00a0Allergy Clin Immunol 131:577\u2013579","journal-title":"J Allergy Clin Immunol"},{"key":"4135_CR39","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/pde.13113","volume":"34","author":"GS Tiplica","year":"2017","unstructured":"Tiplica GS, Kaszuba A, Malinauskiene L et\u00a0al (2017) Prevention of flares in children with atopic dermatitis with regular use of an emollient containing glycerol and paraffin: a randomized controlled study. Pediatr Dermatol 34:282\u2013289","journal-title":"Pediatr Dermatol"},{"key":"4135_CR40","first-page":"509","volume":"111","author":"T Werfel","year":"2014","unstructured":"Werfel T, Schwerk N, Hansen G et\u00a0al (2014) The diagnosis and graded therapy of atopic dermatitis. Dtsch Arztebl Int 111:509\u2013520","journal-title":"Dtsch Arztebl Int"},{"key":"4135_CR41","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jaci.2016.06.010","volume":"138","author":"T Werfel","year":"2016","unstructured":"Werfel T, Allam JP, Biedermann T et\u00a0al (2016) Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J\u00a0Allergy Clin Immunol 138:336\u2013349","journal-title":"J Allergy Clin Immunol"},{"key":"4135_CR42","first-page":"92","volume":"14","author":"T Werfel","year":"2016","unstructured":"Werfel T, Heratizadeh A, Aberer W et\u00a0al (2016) S2k guideline on diagnosis and treatment of atopic dermatitis \u2013 short version. J\u00a0Dtsch Dermatol Ges 14:92\u2013106","journal-title":"J Dtsch Dermatol Ges"},{"key":"4135_CR43","first-page":"73","volume":"14","author":"S Wetzel","year":"2004","unstructured":"Wetzel S, Wollenberg A (2004) Eczema molluscatum in tacrolimus treated atopic dermatitis. Eur J Dermatol 14:73\u201374","journal-title":"Eur J Dermatol"},{"key":"4135_CR44","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1398-9995.2008.01803.x","volume":"64","author":"A Wollenberg","year":"2009","unstructured":"Wollenberg A, Bieber T (2009) Proactive therapy of atopic dermatitis \u2013 an emerging concept. Allergy 64:276\u2013278","journal-title":"Allergy"},{"key":"4135_CR45","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5021\/ad.2012.24.3.253","volume":"24","author":"A Wollenberg","year":"2012","unstructured":"Wollenberg A, Ehmann LM (2012) Long term treatment concepts and proactive therapy for atopic eczema. Ann Dermatol 24:253\u2013260","journal-title":"Ann Dermatol"},{"key":"4135_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s12016-007-0032-9","volume":"33","author":"A Wollenberg","year":"2007","unstructured":"Wollenberg A, Klein E (2007) Current aspects of innate and adaptive immunity in atopic dermatitis. Clin Rev Allergy Immunol 33:35\u201344","journal-title":"Clin Rev Allergy Immunol"},{"key":"4135_CR47","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.iac.2010.06.005","volume":"30","author":"A Wollenberg","year":"2010","unstructured":"Wollenberg A, Schnopp C (2010) Evolution of conventional therapy in atopic dermatitis. Immunol Allergy Clin North Am 30:351\u2013368","journal-title":"Immunol Allergy Clin North Am"},{"key":"4135_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/(SICI)1097-0320(19991001)37:2<147::AID-CYTO8>3.0.CO;2-Y","volume":"37","author":"A Wollenberg","year":"1999","unstructured":"Wollenberg A, Wen S, Bieber T (1999) Phenotyping of epidermal dendritic cells: clinical applications of a\u00a0flow cytometric micromethod. Cytometry 37:147\u2013155","journal-title":"Cytometry"},{"key":"4135_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jaci.2003.07.001","volume":"112","author":"A Wollenberg","year":"2003","unstructured":"Wollenberg A, Wetzel S, Burgdorf WH et\u00a0al (2003) Viral infections in atopic dermatitis: pathogenic aspects and clinical management. J\u00a0Allergy Clin Immunol 112:667\u2013674","journal-title":"J Allergy Clin Immunol"},{"key":"4135_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1067\/S0190-9622(03)00896-X","volume":"49","author":"A Wollenberg","year":"2003","unstructured":"Wollenberg A, Zoch C, Wetzel S et\u00a0al (2003) Predisposing factors and clinical features of eczema herpeticum: a\u00a0retrospective analysis of 100 cases. J\u00a0Am Acad Dermatol 49:198\u2013205","journal-title":"J Am Acad Dermatol"},{"key":"4135_CR51","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1398-9995.2008.01683.x","volume":"63","author":"A Wollenberg","year":"2008","unstructured":"Wollenberg A, Reitamo S, Girolomoni G et\u00a0al (2008) Proactive treatment of atopic dermatitis in adults with 0.1\u202f% tacrolimus ointment. Allergy 63:742\u2013750","journal-title":"Allergy"},{"key":"4135_CR52","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1365-2133.2008.08807.x","volume":"159","author":"A Wollenberg","year":"2008","unstructured":"Wollenberg A, Sidhu MK, Odeyemi I et\u00a0al (2008) Economic evaluation of maintenance treatment with tacrolimus 0.1\u202f% ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 159:1322\u20131330","journal-title":"Br J Dermatol"},{"key":"4135_CR53","first-page":"117","volume":"7","author":"A Wollenberg","year":"2009","unstructured":"Wollenberg A, Frank R, Kroth J et al (2009) Proactive therapy of atopic eczema \u2013 an evidence-based concept with a\u00a0behavioral background. J\u00a0Dtsch Dermatol Ges 7:117\u2013121","journal-title":"J Dtsch Dermatol Ges"},{"key":"4135_CR54","first-page":"117","volume":"7","author":"A Wollenberg","year":"2009","unstructured":"Wollenberg A, Frank R, Kroth J et\u00a0al (2009) Proaktive Therapie des atopischen Ekzems \u2013 Ein evidenzbasiertes Therapiekonzept mit verhaltenstherapeutischem Hintergrund. J\u00a0Dtsch Dermatol Ges 7:117\u2013121","journal-title":"J Dtsch Dermatol Ges"},{"key":"4135_CR55","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12016-010-8227-x","volume":"41","author":"A Wollenberg","year":"2011","unstructured":"Wollenberg A, R\u00e4wer HC, Schauber J (2011) Innate immunity in atopic dermatitis. Clin Rev Allergy Immunol 41:272\u2013281","journal-title":"Clin Rev Allergy Immunol"},{"key":"4135_CR56","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/jdv.13599","volume":"30","author":"A Wollenberg","year":"2016","unstructured":"Wollenberg A, Oranje A, Deleuran M et\u00a0al (2016) ETFAD\/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. J\u00a0Eur Acad Dermatol Venereol 30:729\u2013747","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4135_CR57","doi-asserted-by":"crossref","unstructured":"Wollenberg A, F\u00f6lster-Holst R, Saint-Aroman M et al (2018) Effects of a\u00a0protein-free oat plantlet extract on microinflammation and skin barrier function in atopic dermatitis patients. J Eur Acad Derm Venereol, in press","DOI":"10.1111\/jdv.14846"},{"key":"4135_CR58","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/bjd.15602","volume":"177","author":"EJ Zuuren Van","year":"2017","unstructured":"Van Zuuren EJ, Fedorowicz Z, Arents BWM (2017) Emollients and moisturizers for eczema: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol 177:1256\u20131271","journal-title":"Br J Dermatol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-018-4135-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-018-4135-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T23:10:17Z","timestamp":1570835417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-018-4135-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,27]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4135"],"URL":"https:\/\/doi.org\/10.1007\/s00105-018-4135-4","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,27]]},"assertion":[{"value":"27 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Knop, A.\u00a0G\u00fcrtler und N.\u00a0Aszodi geben an, dass kein Interessenkonflikt besteht. A.\u00a0Heratizadeh gibt honorierte Beratungen und Vortr\u00e4ge f\u00fcr die Firmen Pierre Fabre, Beiersdorf und Novartis an. T.\u00a0Werfel gibt honorierte Vortr\u00e4ge, Teilnahme an honorierten klinischen Studien und\/oder Beratung der Firmen Galderma, Janssen, Novartis, Sanofi und Ziarco an. A.\u00a0Wollenberg gibt honorierte Vortr\u00e4ge, Teilnahme an honorierten klinischen Studien und\/oder Beratung der Firmen Almirall, Beiersdorf, Bioderma, Chugai, Galderma, Hans Karrer, LEO, Novartis, Pfizer, Pierre Fabre, Regeneron und Sanofi an.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}